Pacific Biosciences of California Inc. sell Barclays PLC
Start price
06.03.26
/
50%
€1.30
Target price
06.03.27
€1.29
Performance (%)
-10.17%
Price
21.08.26
€1.17
Summary
This prediction is currently active. The prediction for Pacific Biosciences of California Inc. shows a convincing performance of -10.17%. This prediction currently runs until 06.03.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pacific Biosciences of California Inc. | 17.087% | 17.087% |
| iShares Core DAX® | -1,28 % | 4,21 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % |
| iShares S&P 500 | -2,31 % | -0,10 % |
Comments by Barclays_PLC for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California (PACB) had its "underweight" rating reaffirmed by Barclays PLC. They now have a $1.50 price target on the stock.
Ratings data for PACB provided by MarketBeat
Stopped prediction by Barclays_PLC for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.18
11.05.26
11.05.26
€1.28
11.05.27
11.05.27
-0.76%
21.08.26
21.08.26
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.28
14.04.26
14.04.26
€0.85
14.04.27
14.04.27
-19.57%
21.08.26
21.08.26